Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

IDRA 4.06 +0.17 (4.37%)
price chart
Idera Pharmaceuticals Inc (NASDAQ:IDRA) Top Pick at Piper Jaffray
[The Fly] Piper Jaffray calls Idera Pharmaceuticals Inc (NASDAQ:IDRA) a top small cap pick for 2015 and reiterates an Overweight rating on the name with a $7 price target.
Idera Pharmaceuticals Director Youssef El Zein Sells 100000 Shares (IDRA)  Ticker Report
News Review -Idera Pharmaceuticals (IDRA),Cosan (CZZ),Hersha Hospitality ...  Techsonian (press release)
Related articles »  
Stock to Watch: Idera Pharmaceuticals Inc (NASDAQ:IDRA)
[Globe NewsWIRE] Idera Pharmaceuticals Inc (NASDAQ:IDRA) (TREND ANALYSIS), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for cancers and rare diseases, announced that it has appointed J. Peter Wolf as Senior ...
Idera Pharmaceuticals (IDRA) Marked As A Dead Cat Bounce Stock  TheStreet.com
Idera Pharmaceuticals CEO Buys $800000 in Stock (IDRA)  Dakota Financial News
Related articles »  
Idera Pharmaceuticals: A Star In The Making (IDRA)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) is a biotechnology company engaged in discovering and developing Toll-Like Receptors (TLRs) antagonists, novel-synthetic DNA and RNA based drug candidates.
Related articles »  
Idera Pharmaceuticals (IDRA) Stock Rises After Cancer Drug Shows Anti-Tumor ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced after markets closed Tuesday that its immunotherapy intratumoral injection candidate, IMO-2055, showed anti-tumor activity in combination with Bristol-Myers Squibb Co's (NYSE:BMY) Yervoy against a ...
Idera Pharmaceuticals Announces Cancer Immunotherapy Regimen With ...  MarketWatch
Related articles »  
Stock Insights on Idera Pharmaceuticals Inc (NASDAQ:IDRA)
[AP] Idera Pharmaceuticals Inc (NASDAQ:IDRA) (Trend Analysis) reported a loss of $9.5 million, or 11 cents per share, in its third quarter.
HealthCare Sector Gainers: Idera Pharmaceuticals Inc (IDRA), Rigel ...  Street Register
Related articles »  
Should You Invest In FuelCell Energy Inc (FCEL), Idera Pharmaceuticals Inc ...
Idera Pharmaceuticals Inc(NASDAQ:IDRA) announced yesterday that it had appointed J. Peter Wolf to the position of Senior Vice President, General Counsel and Elizabeth Eberhardt as the company's new Vice President, Oncology Team.
Related articles »  
Idera Pharmaceuticals Inc. (IDRA) Leads Small-Cap Stars in Early Trading for ...
Equities.com created the Small-Cap Stars, our proprietary list of small-cap companies best-positioned for future success, to help investors identify those small-cap companies with the most fundamental strength and the best chance for future success.
Related articles »  
Idera Pharmaceuticals Inc.: Idera Pharmaceuticals Names Vincent J. Milano ...
CAMBRIDGE, Mass., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for cancers and rare diseases, announced that it has appointed Vincent ...
Related articles »  
Form 8-K IDERA PHARMACEUTICALS, For: Dec 16
On December 16, 2014, Participations Besancon converted 110,901 shares of Idera Pharmaceuticals, Inc.'s (the �Company�) Series E convertible preferred stock (�Series E preferred stock�) into 2,218,020 shares of the Company's common stock in ...
Related articles »  
Idera Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
Idera Pharmaceuticals, Inc. IDRA, +3.76% a clinical-stage biopharmaceutical company developing novel nucleic acid therapeutics for cancer and rare diseases, today announced that Company management will present at the 26th Annual Piper Jaffray ...
Related articles »